{
    "nct_id": "NCT04299048",
    "official_title": "A PHASE 1B, 12-WEEK, OPEN-LABEL STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS FOLLOWING REPEATED SUBCUTANEOUS ADMINISTRATIONS OF PF-06946860 IN PATIENTS WITH CANCER AND CACHEXIA",
    "inclusion_criteria": "* Documented histologic or cytologic diagnosis of advanced metastatic NSCLC, advanced/unresectable pancreatic cancer, or metastatic colorectal cancer.\n* Cachexia, defined by BMI <20 kg/m2 with involuntary weight loss of >2% within 6 months prior to screening or Involuntary weight loss of >5% within 6 months prior to screening irrespective of BMI or If medical record documentation is unavailable, patient's report will suffice to estimate involuntary body weight loss.;\n* Will receive the following for non-small cell lung cancer:\n\n  * a platinum + pemetrexed ± pembrolizumab or\n  * a platinum + nab paclitaxel or paclitaxel ± pembrolizumab or\n  * pembrolizumab alone\n* Will receive the following for pancreatic cancer:\n\n  * FOLFIRINOX or\n  * Nab-Paclitaxel + Gemcitabine\n  * Gemcitabine\n* Will receive the following for colorectal cancer:\n\n  * FOLFOX +/- Biologic (Bevacizumab or Cetuximab/Panitumumab) or\n  * FOLFIRI +/- Biologic (Bevacizumab or Cetuximab/Panitumumab) or\n  * FOLFOXIRI +/- Biologic (Bevacizumab or Cetuximab/Panitumumab) or\n  * Pembrolizumab for MSI-H • Will be entering the study at the first or second cycle of their current course of anti-cancer treatment/ therapy.\n* Adequate renal and liver function.\n* Signed informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* All other forms of cancers not specified above unless currently considered cured (>5 years without evidence of recurrence).\n* Planned radiation therapy as part of the primary anti-tumor therapy regimen. However, localized radiation therapy for symptomatic relief is permitted\n* Cachexia caused by other reasons: Severe COPD requiring use of home O2, heart failure or AIDS.\n* known symptomatic brain metastases requiring steroids.\n* Active hepatitis B or C virus.\n* Confirmed positive HIV test.\n* Current active reversible causes of decreased food intake.\n* Receiving tube feedings or parenteral nutrition at Screening.\n* Elevated blood pressure that cannot be controlled by medications.\n* Women who are pregnant or breast-feeding",
    "miscellaneous_criteria": ""
}